Search

everythinglearnresearchcommunity

for

Search:↓

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Different human traits like skin color and hair type vary between populations due to genetic adaptations to the environment.

Testosterone significantly affects urination differences between male and female mice.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Anabolic steroids and SARMs can cause serious liver damage.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

MendelVar is a tool that helps identify important genes by combining GWAS data with Mendelian disease information.

Testosterone pellet therapy may better address hormone imbalances in aging by focusing on local hormone production and symptom relief.

Women with PCOS have higher cardiometabolic risks.

Shi-Bi-Man activates hair follicle stem cells and promotes hair growth by changing lactic acid metabolism and other cellular processes.

Tiny particles from 3D-grown skin cells speed up wound healing by promoting blood vessel growth.

Hair loss in women may have multiple causes, and eyebrow regrowth possible with specific injections.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Kennedy's disease leads to muscle weakness without a cure, but exercise and managing symptoms may help patients live a normal lifespan.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Increased PPARGC1α relates to hair thinning in common baldness.

Hair loss patterns differ between males and females due to 5 master regulators and JAK-STAT signaling affects hair growth.

Androgens in female meerkats influence aggression and dominance, affecting social dynamics and offspring behavior.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.